KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Quest Diagnostics (DGX) Receivables - Other (2016 - 2021)

Quest Diagnostics (DGX) has disclosed Receivables - Other for 9 consecutive years, with $5.0 million as the latest value for Q1 2021.

  • Quarterly Receivables - Other changed 0.0% to $5.0 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Mar 2021, changed 0.0% year-over-year, with the annual reading at $3.0 million for FY2020, 25.0% down from the prior year.
  • Receivables - Other hit $5.0 million in Q1 2021 for Quest Diagnostics, up from $3.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $13.0 million in Q2 2017 to a low of $2.0 million in Q1 2019.
  • Historically, Receivables - Other has averaged $4.6 million across 5 years, with a median of $4.0 million in 2018.
  • Biggest five-year swings in Receivables - Other: crashed 76.92% in 2018 and later surged 150.0% in 2020.
  • Year by year, Receivables - Other stood at $3.0 million in 2017, then changed by 0.0% to $3.0 million in 2018, then skyrocketed by 33.33% to $4.0 million in 2019, then dropped by 25.0% to $3.0 million in 2020, then soared by 66.67% to $5.0 million in 2021.
  • Business Quant data shows Receivables - Other for DGX at $5.0 million in Q1 2021, $3.0 million in Q4 2020, and $4.0 million in Q3 2020.